Further support for a critical role of apoE-mediated removal of beta-amyloid are recent studies demonstrating the administration of anti-cancer drug, bexarotene in an animal model of AD, enhanced clearance of beta-amyloid and reversed cognitive impairments in an apoE-dependent manner [53,54]. This evidence concerns the gene APOE and Alzheimer disease.